BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25323700)

  • 1. Clinical and neuroimaging characterization of Chinese dementia patients with PSEN1 and PSEN2 mutations.
    Shi Z; Wang Y; Liu S; Liu M; Liu S; Zhou Y; Wang J; Cai L; Huo YR; Gao S; Ji Y
    Dement Geriatr Cogn Disord; 2015; 39(1-2):32-40. PubMed ID: 25323700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene mutations in a Han Chinese Alzheimer's disease cohort.
    Ma L; Zhang J; Shi Y; Wang W; Ren Z; Xia M; Zhang Y; Yang M
    Brain Behav; 2019 Jan; 9(1):e01180. PubMed ID: 30549411
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Giau VV; Bagyinszky E; Youn YC; An SSA; Kim S
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer's disease and frontotemporal dementia.
    Pagnon de la Vega M; Näslund C; Brundin R; Lannfelt L; Löwenmark M; Kilander L; Ingelsson M; Giedraitis V
    BMC Genomics; 2022 Feb; 23(1):99. PubMed ID: 35120450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation profile of APP, PSEN1, and PSEN2 in Chinese familial Alzheimer's disease.
    Gao Y; Ren RJ; Zhong ZL; Dammer E; Zhao QH; Shan S; Zhou Z; Li X; Zhang YQ; Cui HL; Hu YB; Chen SD; Chen JJ; Guo QH; Wang G
    Neurobiol Aging; 2019 May; 77():154-157. PubMed ID: 30822634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation screening in Chinese patients with familial Alzheimer's disease by whole-exome sequencing.
    Jiang B; Zhou J; Li HL; Chen YG; Cheng HR; Ye LQ; Liu DS; Chen DF; Tao QQ; Wu ZY
    Neurobiol Aging; 2019 Apr; 76():215.e15-215.e21. PubMed ID: 30598257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
    Lanoiselée HM; Nicolas G; Wallon D; Rovelet-Lecrux A; Lacour M; Rousseau S; Richard AC; Pasquier F; Rollin-Sillaire A; Martinaud O; Quillard-Muraine M; de la Sayette V; Boutoleau-Bretonniere C; Etcharry-Bouyx F; Chauviré V; Sarazin M; le Ber I; Epelbaum S; Jonveaux T; Rouaud O; Ceccaldi M; Félician O; Godefroy O; Formaglio M; Croisile B; Auriacombe S; Chamard L; Vincent JL; Sauvée M; Marelli-Tosi C; Gabelle A; Ozsancak C; Pariente J; Paquet C; Hannequin D; Campion D;
    PLoS Med; 2017 Mar; 14(3):e1002270. PubMed ID: 28350801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pathogenic
    Giau VV; Pyun JM; Bagyinszky E; An SSA; Kim S
    Clin Interv Aging; 2018; 13():1321-1329. PubMed ID: 30104866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double Mutations in a Patient with Early-Onset Alzheimer's Disease in Korea: An
    Bae H; Shim KH; Yoo J; Yang YS; An SSA; Kang MJ
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families.
    Cruchaga C; Haller G; Chakraverty S; Mayo K; Vallania FL; Mitra RD; Faber K; Williamson J; Bird T; Diaz-Arrastia R; Foroud TM; Boeve BF; Graff-Radford NR; St Jean P; Lawson M; Ehm MG; Mayeux R; Goate AM;
    PLoS One; 2012; 7(2):e31039. PubMed ID: 22312439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic screening in early-onset Alzheimer's disease identified three novel presenilin mutations.
    Wong TH; Seelaar H; Melhem S; Rozemuller AJM; van Swieten JC
    Neurobiol Aging; 2020 Feb; 86():201.e9-201.e14. PubMed ID: 30797548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presenilin 1 and APP Gene Mutations in Early-Onset AD Families from a Southeast Region of China.
    Zhou J; Chen Y; Meng F; Zhang K; Liu X; Peng G
    Curr Alzheimer Res; 2020; 17(6):540-546. PubMed ID: 32579498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease.
    Sassi C; Guerreiro R; Gibbs R; Ding J; Lupton MK; Troakes C; Al-Sarraj S; Niblock M; Gallo JM; Adnan J; Killick R; Brown KS; Medway C; Lord J; Turton J; Bras J; ; Morgan K; Powell JF; Singleton A; Hardy J
    Neurobiol Aging; 2014 Dec; 35(12):2881.e1-2881.e6. PubMed ID: 25104557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genetic screen of the mutations in the Korean patients with early-onset Alzheimer's disease.
    An SS; Park SA; Bagyinszky E; Bae SO; Kim YJ; Im JY; Park KW; Park KH; Kim EJ; Jeong JH; Kim JH; Han HJ; Choi SH; Kim S
    Clin Interv Aging; 2016; 11():1817-1822. PubMed ID: 28008242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presenilin-1 (PSEN1) Mutations: Clinical Phenotypes beyond Alzheimer's Disease.
    Yang Y; Bagyinszky E; An SSA
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's disease.
    Sassi C; Guerreiro R; Gibbs R; Ding J; Lupton MK; Troakes C; Lunnon K; Al-Sarraj S; Brown KS; Medway C; Lord J; Turton J; Mann D; Snowden J; Neary D; Harris J; Bras J; ; Morgan K; Powell JF; Singleton A; Hardy J
    Neurobiol Aging; 2014 Oct; 35(10):2422.e13-6. PubMed ID: 24880964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations.
    Pimenova AA; Goate AM
    Neurobiol Dis; 2020 May; 138():104785. PubMed ID: 32032730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.
    Gordon BA; Blazey TM; Su Y; Hari-Raj A; Dincer A; Flores S; Christensen J; McDade E; Wang G; Xiong C; Cairns NJ; Hassenstab J; Marcus DS; Fagan AM; Jack CR; Hornbeck RC; Paumier KL; Ances BM; Berman SB; Brickman AM; Cash DM; Chhatwal JP; Correia S; Förster S; Fox NC; Graff-Radford NR; la Fougère C; Levin J; Masters CL; Rossor MN; Salloway S; Saykin AJ; Schofield PR; Thompson PM; Weiner MM; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
    Lancet Neurol; 2018 Mar; 17(3):241-250. PubMed ID: 29397305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer's disease.
    Course MM; Gudsnuk K; Keene CD; Bird TD; Jayadev S; Valdmanis PN
    Brain; 2023 Feb; 146(2):507-518. PubMed ID: 35949106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Phenotype and Mutation Spectrum of Alzheimer's Disease with Causative Genetic Mutation in a Chinese Cohort.
    Mao C; Li J; Dong L; Huang X; Lei D; Wang J; Chu S; Liu C; Peng B; Román GC; Cui L; Gao J
    Curr Alzheimer Res; 2021; 18(3):265-272. PubMed ID: 34102969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.